Skip to content

Effects of Gamma-tACS on EEG Periodic Activity

Evaluation of the Effects of Gamma-tACS on the Periodic Activity of Neural Signals as a Function of State-dependency

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05809076
Acronym
GAMMAtACS
Enrollment
34
Registered
2023-04-12
Start date
2021-07-20
Completion date
2023-01-18
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transcranial Alternating Current Stimulation

Brief summary

In this study on healthy subjects, the effect of transcranial alternating current stimulation (tACS) will be investigated. In particular, the distinction between periodic and aperiodic electroencephalogram (EEG) activity will be considered, as well as the state-dependency phenomenon. Participants will take part in two experimental sessions that will include tACS stimulation (one real, one control). Before, during, and after stimulation, subjects will have their EEG recorded during rest or during tasks. The aim of this study is to investigate how the modulatory effects of gamma-tACS interact with intrinsic neural activity, measured in terms of periodic and aperiodic activity, as well as neurophysiological and behavioral modulation, taking into consideration the state-dependency phenomenon, which refers to the brain's activation state prior to stimulation.

Interventions

DEVICEreal tACS

tACS is a non-invasive method to induce brain modulation. It will be applied at a frequency of 40 Hz (gamma-tACS) with a peak-to-peak intensity of 2 mA. During the real tACS condition, the alternating current will be administered for 20 minutes.

DEVICEsham tACS

In the sham tACS condition, the current will be delivered only for the first 30 seconds and then stopped, in order to simulate the same somatosensory sensations as real tACS, but without inducing modulation.

Sponsors

IRCCS San Camillo, Venezia, Italy
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- Healthy adults

Exclusion criteria

* Common

Design outcomes

Primary

MeasureTime frameDescription
resting-state electroencephalography (EEG) signalbaselineThe periodic and aperiodic activity of the EEG signal will be estimated through Brainstorm (i.e., EEG analysis software) and quantified in terms of numerical values representing the periodic/aperiodic component of the EEG signal. The periodic and aperiodic activity of the EEG signal will be assessed during three time frames: baseline, during the intervention, and immediately after the intervention (real or sham tACS)

Secondary

MeasureTime frameDescription
behavioral performance (response times)baselineParticipants' motor performance at a computerized task will be measured in terms of response times (how fast the participants press a computer button, according to the task's instructions). The participants' motor performance will be assessed during two time frames: baseline and immediately after the intervention (real or sham tACS)
behavioral performance (accuracy)baselineParticipants' motor performance at a computerized task will be measured in terms of accuracy (% of correct responses at the computerized task, according to the task's instructions). The participants' motor performance will be assessed during two time frames: baseline and immediately after the intervention (real or sham tACS)
auditory steady state response (ASSR)baselineThe auditory steady state response will be measured via EEG during entrainment through exposure to amplitude-modulated 40Hz sounds (5 min, sequence of amplitude-modulated tones at 40 Hz, delivered via earplug binaurally). The auditory steady state response will be measured as power of the EEG gamma band. The auditory steady state response will be assessed during two time frames: baseline and immediately after the intervention (real or sham tACS)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026